# A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190

> **NCT04455230** · PHASE1,PHASE2 · COMPLETED · sponsor: **Spur Therapeutics** · enrollment: 3 (actual)

## Conditions studied

- Fabry Disease
- Lysosomal Storage Diseases

## Interventions

- **GENETIC:** FLT190

## Key facts

- **NCT ID:** NCT04455230
- **Lead sponsor:** Spur Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-08
- **Primary completion:** 2023-09-28
- **Final completion:** 2023-09-28
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2023-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04455230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04455230, "A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04455230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*